Quote:
Originally Posted by Chris
AstraZeneca has suggested that the urgent nature of the situation led it to publish what it had earlier rather than wait to publish more later. In the past some have observed that AstraZeneca lacks experience in vaccine development. The USA’s response to it was however extremely heavy handed, though as Hugh has since suggested that might just be typical of the institutional culture of the FDA.
|
The authorities in the USA told them in advance for their press release the figures to include. They chose not to. I doubt that's inexperience in vaccine development so much as plenty of experience in PR.